共 33 条
[6]
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design
[J].
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE,
2011, 2 (04)
:201-207